Eyeworld

APR 2016

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/664255

Contents of this Issue

Navigation

Page 165 of 242

163 April 2016 EW MEETING REPORTER cataract surgery for greater amounts of cylinder are preferred. Richard Tipperman, MD, Bala Cynwyd, Pennsylvania, highlighted the 4 types of toric IOLs currently on the market and said "the oppor- tunity to correct patients' complete refractive error, including their astigmatism, far outweighs the rare potential of lens rotation," a situa- tion that could affect the refractive outcome. Using the right formulas—and several of them—to calculate IOL power to achieve the best refrac- tive outcome is important as well, Dr. Donnenfeld said. Calculating IOL power for a patient with prior corneal refractive surgery requires measurement of both the anterior and posterior corneal refractive pow- er, effective lens placement, and the ability to confirm the correct IOL power intraoperatively, if possible. Residual astigmatism after toric IOL implants can result from a variety of factors including the wrong IOL calculation, the implant being oriented on the wrong axis or rotating, corneal edema, ocular sur- face disease, or epithelial basement membrane dystrophy. In the event of residual astigma- tism, Tal Raviv, MD, New York, said physicians should determine if the IOL was placed on the intended axis, if that axis was appropriate, whether the IOL rotated, and if the right IOL power was selected. When it comes to selecting the correct IOL power, Dr. Raviv reminded the audience about the importance of taking into account posterior astigmatism, which intra- operative aberrometry does, for the best refractive outcome. Treatment options for residual astigmatism include LASIK/PRK, IOL rotation, IOL exchange, or prescribing glasses or contacts. Dr. Solomon recommended www.astigmatismfix.com for cases of residual astigmatism with toric IOLs to help determine the best course of action. Christopher Starr, MD, New York, spoke about how ocular surface disease and meibo- mian gland disease (MGD) could affect refractive outcomes."The tear film is arguably the most important refracting interface in the eye," he said, recommending tear testing for all patients and treating any ocu- lar surface disease prior to cataract surgery. continued on page 164

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - APR 2016